TURBO-BULL-CERTIFICATE - IPSEN | Real-time Euronext Paris 16:25:05 04/06/2024 BST | ||
| 1.845 EUR | -1.60% |
|
| Current month | +3.31% | ||
| 1 month | +25.42% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
| Date | Price | Change |
|---|---|---|
| 04/06/24 | 1.845 | -1.60% |
| 03/06/24 | 1.875 | +3.31% |
| 31/05/24 | 1.815 | +2.83% |
| 30/05/24 | 1.765 | +1.15% |
| 29/05/24 | 1.745 | +0.58% |
Real-time Euronext Paris
Last update June 04, 2024 at 04:25 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 9R78S | |
| ISIN | DE000SW72DJ5 |
| Date issued | 21/03/2024 |
| Strike | 85 € |
| Maturity | 21/06/2024 (17 Days) |
| Parity | 20 : 1 |
| Emission price | 1 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.975 € |
|---|---|
| Lowest since issue | 1.035 € |
| Spread | 0.01 € |
| Spread % | 0.54% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
121.8
EUR
Average target price
126.4
EUR
Spread / Average Target
+3.78%
- Stock Market
- Certificates
- 9R78S Certificat